Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Kloetzer, A
Key Takeaways AOD 9604 produces 2-3 times greater fat loss than placebo in clinical trials with women Standard dosing ranges from 0.5mg to 1mg daily via subcutaneous injection Side effects occur in fewer than 5% of women, primarily mild injection site reactions Results typically become visible after 4-6 weeks of consistent daily administration The peptide preserves lean muscle mass while specifically targeting fat tissue How AOD 9604 Works for Female Fat Loss AOD 9604 functions by activating beta-3 adrenergic receptors in adipose tissue, specifically triggering lipolysis without the growth-promoting effects of full-length growth hormone
A GLP-1 medication, dosed and used under the supervision of a doctor, may be the type of peptide you need to help you achieve your goals
confirm exact fragment MW with the product team), studied for systemic effects on actin sequestration, cell migration, and vascular development [6]
Phase 2: Days 16-30 (2 mg/day) From day 16 onward, the dose doubles to 8 units (2 mg per injection)
